D2B3

New Haven, United States

D2B3is a pre-clinical biotechnology startup dedicated to creating innovative drug delivery technologies for the brain.

$500K raised

Apr 2025

Pre-Seed

Top Investors

Mission BioCapital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has D2B3 raised?

D2B3 has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2025.

Who are D2B3's investors?

D2B3's investors include Mission BioCapital.

Where is D2B3 headquartered?

D2B3 is headquartered in New Haven, United States.

What does D2B3 do?

D2B3is a pre-clinical biotechnology startup dedicated to creating innovative drug delivery technologies for the brain.

What stage is D2B3 at?

D2B3 is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 7, 2025.

MLA

"D2B3 — Funding & Investors." VCBacked, April 7, 2025, https://www.vcbacked.co/company/d2b3. Accessed June 17, 2026.

APA

VCBacked. (2025). D2B3 — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/d2b3

Wikipedia (cite web)

{{cite web |title=D2B3 — Funding & Investors |url=https://www.vcbacked.co/company/d2b3 |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 7, 2025.